A comparison of ex vivo expanded DCs derived from cord blood and mobilized adult peripheral blood plastic-adherent mononuclear cells: Decreased alloreactivity of cord blood DCs

Cytotherapy

Volumn 5, Issue 5, 2003, Pages 349-361

  Bracho, F ^a   Van De Ven, C ^b   Areman, E ^c   Hughes, R M ^d   Davenport, V ^b   Bradley, M B ^b   Cai, J W ^b   Cairo, Mitchell S ^b  

^a GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^d BECKMAN COULTER INC   (United States)

Author keywords

Alloreactivity; Cord blood; Dendritic cell; FLT 3 ligand; Monocyte; Peripheral blood

Indexed keywords

B7 ANTIGEN; BIOCHEMICAL MARKER; CANCER GROWTH FACTOR; CANCER GROWTH FACTOR BETA; CD14 ANTIGEN; CD83 ANTIGEN; FLT3 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 4; PACLITAXEL; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; T6 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADHERENT CELL; ADOPTIVE IMMUNOTHERAPY; ADULT; ALLOIMMUNITY; ALLOTRANSPLANTATION; ANTIGEN EXPRESSION; ARTICLE; BLOOD AUTOTRANSFUSION; BREAST CANCER; CANCER CHEMOTHERAPY; CELL CULTURE; CELL STRUCTURE; CELL SURVIVAL; CELL TRANSPLANTATION; CLONOGENESIS; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; DISEASE SEVERITY; EX VIVO STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INCIDENCE; INFECTION; LYMPHOCYTE COUNT; MONONUCLEAR CELL; PHENOTYPE; STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TYPES OF STUDY; UMBILICAL CORD BLOOD;

EID: 0242468554     PISSN: 14653249     EISSN: None     Source Type: Journal    
DOI: 10.1080/14653240310003017     Document Type: Article

References (49)

1. Wagner JE, Rosenthal J, Sweetman R et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease. Blood 1996;88:795-802.
2. Laughlin MJ, Barker J, Bambach B et al. Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors. N Engl J Med 2001;344:1815-22.
3. Cairo MS, Wagner JE. Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation. Blood 1997;90:4665-78.
4. Rubinstein P, Carrier C, Scaradavou A et al. Outcomes among 562 recipients of placental-blood transplants from unrelated donors [see comments]. N Engl J Med 1998;339:1565-77.
5. Abu-Ghosh A, Goldman S, Slone V et al. Immunological reconstitution and correlation of circulating serum inflammatory mediators/cytokines with the incidence of acute graft- versus-host disease during the first 100 days following unrelated umbilical cord blood transplantation. Bone Marrow Transplant 1999;24:535-44.
6. Cairo M, Suen Y, Knoppel E, et al. Decreased stimulated GM-CSF production and GM-CSF gene expression but normal numbers of GM-CSF receptors in human term newborns compared to adults. Pediatr Res 1991;30:362-7.
7. Cairo MS, Suen Y, Knoppel E, et al. Decreased G-CSF and IL-3 production and gene expression from mononuclear cells of newborn infants. Pediatr Res 1992;31:574-8.
8. Qian JX, Lee SM, Suen Y et al. Decreased interleukin-15 from activated cord versus adult peripheral blood mononuclear cells and the effect of interleukin-15 in upregulating antitumor immune activity and cytokine production in cord blood. Blood 1997;90:3106-17.
9. Lee SM, Suen Y, Chang L et al. Interleukin-12 (IL-12) from activated cord versus adult peripheral blood mononuclear cells and upregulation of interferon-gamma, natural killer, and lymphokine-activated killer activity by IL- 12 in cord blood mononuclear cells. Blood 1996;88:945-54.
10. Suen Y, Lee SM, Schreurs J et al. Decreased macrophage colony-stimulating factor mRNA expression from activated cord versus adult mononuclear cells: Altered posttranscriptional stability. Blood 1994;84:4269-77.
11. Wu J, Cairo S, Van De Ven C et al. Significant downregulation of Interleukin (IL-)-18 gene expression and protein production in constitutive and activated umbilical cord blood (CB) vs adult peripheral blood (APB) mononuclear cells (MNC): Potential mechanism for differential alloreactivity. Blood 2001;98:205a.
12. Bracho F, Goldman S, Cairo MS. Potential use of granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in neonates. Curr Opin Hematol 1998;5:215-20.
13. Gaddy J, Risdon G, Broxmeyer HE. Blood natural killer cells are functionally and phenotypically immature but readily respond to interleukin-2 and interleukin-12. J Interferon Cytokine Res 1995;15:527-36.
14. Cohen SB, Dominguez E, Lowdell M, Madrigal JA. Immunological properties of cord blood: Overview of current research presented at the 2nd EUROCORD workshop. Bone Marrow Transplant 1998;22(Suppl 1):S22-5.
15. Miyagawa Y, Sugita K, Komiyama A, Akabane T. Delayed in vitro immunoglobulin production by cord lymphocytes. Pediatrics 1980;65:497-500.
16. Banchereau J, Briere F, Caux C et al. Immunobiology of dendritic cells. Annu Rev Immunol 2000;18:767-811.
17. Steinman R, Inaba K. Immunogenicity: Role of dendritic cells. Bioessays 1989;10:145-52.
18. Cella M, Jarrossay D, Facchetti F et al. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat Med 1999;5:919-23.
19. Borras FE, Matthews NC, Lowdell MW, Navarrete CV. Identification of both myeloid CD11c+ and lymphoid CD11c- dendritic cell subsets in cord blood. Br J Haematol 2001;113:925-31.
20. Sorg RV, Kogler G, Wernet P. Identification of cord blood dendritic cells as an immature CD11c- population. Blood 1999;93:2302-7.
21. Caux C, Dezutter-Dambuyant C, Schmitt D, Banchereau J. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. Nature 1992;360:258-61.
22. Fraser JK, Cairo MS, Wagner EL: et al. Cord Blood Transplantation Study (COBLT): Cord blood bank standard operating procedures. J Hematother 1998;7:521-61.
23. Meehan KR, Arun B, Gehan EA et al. With interleukin-2 and alpha-interferon after IL-2-activated hematopoietic stem cell transplantation for breast cancer. Bone Marrow Transplant 1999;23:667-73.
24. + bone marrow progenitors that are expanded by c-kit-ligand and yield pure dendritic cell colonies in the presence of granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alpha [published erratum appears in J Exp Med 1995 Mar 1;183:1283]. J Exp Med 1996;182:1111-9.
25. Hunt DW, Huppertz HI, Jiang HJ, Petty RE. Studies of human cord blood dendritic cells: Evidence for functional immaturity. Blood 1994;84:4333-43.
26. George-Chandy A, Mielcarek N, Nordstrom I et al. Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection. Infect Immun 2001;69:4120-4.
27. Liso A, Stockerl-Goldstein KE, Auffermann-Gretzinger S et al. Idiotype vaccination using dendritic cells after autologous peripheral blood progenitor cell transplantation for multiple myeloma. Biol Blood Marrow Transplant 2000;6:621-7.
28. Avigan D, Wu Z, Gong J et al. Selective in vivo mobilization with granulocyte macrophage colony-stimulating factor (GM-CSF)/granulocyte-CSF as compared to G-CSF alone of dendritic cell progenitors from peripheral blood progenitor cells in patients with advanced breast cancer undergoing autologous transplantation. Clin Cancer Res 1999;5:2735-41.
29. + progenitors in bone marrow and cord blood. Br J Haematol 1996;93:258-64.
30. Szabolcs P, Avigan D, Gezelter S et al. Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. Blood 1996;87:4520-30.
31. Broxmeyer HE, Douglas GW, Hangoc G et al. Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci USA 1989;86:3828-32.
32. + hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+ TNF alpha. J Exp Med 1996;184:695-706.
33. Zhang Y, Mukaida N, Wang J et al. Induction of dendritic cell differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor, and tumor necrosis factor alpha in vitro from lineage phenotypes-negative c-kit+ murine hematopoietic progenitor cells. Blood 1997;90:4842-53.
34. Strobl H, Bello-Fernandez C, Riedl E et al. Ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 1997;90:1425-34.
35. + progenitors in serum-free medium. Adv Exp Med Biol 1997;417:161-5.
36. + progenitor cells. Exp Hematol 1998;26:489-500.
37. + hematopoietic progenitors: Phenotypic and functional analysis. Haematologica 2000;85:989-90.
38. + precursor cells develop into Langerhans cells in a TGF-beta 1-dependent manner. J Immunol 1999;163:4869-77.
39. Sorg RV, Andres S, Kogler G et al. Phenotypic and functional comparison of monocytes from cord blood and granulocyte colony-stimulating factor-mobilized apheresis products. Exp Hematol 2001;29:1289-94.
40. Georgelas A, Schibler K. Characterization of myeloid and lymphoid subsets in dendritic cells derived from cord blood and adult blood. Exp Hematol 2000;28:1499.
41. Zheng Z, Takahashi M, Narita M et al. Generation of dendritic cells from adherent cells of cord blood by culture with granulocyte-macrophage colony-stimulating factor, interleukin-4, and tumor necrosis factor-alpha. J Hematother Stem Cell Res 2000;9:453-64.
42. Liu E, Tu W, Law HK, Lau YL. Decreased yield, phenotypic expression and function of immature monocyte-derived dendritic cells in cord blood. Br J Haematol 2001;113:240-6.
43. Keever CA, Abu-Hajir M, Graf W et al. Characterization of the alloreactivity and anti-leukemia reactivity of cord blood mononuclear cells. Bone Marrow Transplant 1995;15:407-19.
44. Goriely S, Vincart B, Stordeur P et al. Deficient IL-12(p35) gene expression by dendritic cells derived from neonatal monocytes. J Immunol 2001;166:2141-6.
45. Porcu P, Gaddy J, Broxmeyer HE. Alloantigen-induced unresponsiveness in cord blood T lymphocytes is associated with defective activation of Ras. Proc Natl Acad Sci USA 1998;95:4538-43.
46. Kurtzberg J, Martin P, Szabolcs P et al. Outcomes of unrelated umbilical cord blood transplantation in 158 pediatric patients consecutively transplanted at a single institution using cord blood units from a single bank. Blood 2000;96(Suppl 1):206a.
47. Deeg HJ. Graft-versus-host disease: Host and donor views. Semin Hematol 1993;30(Suppl 4):110-7.
48. Haridas V, Kamat RS. Antigen-presenting cells (APC) of mice with chronic graft-versus-host disease (GVHD) cause excessive activation-induced death of T helper cells. Clin Exp Immunol 1997;110:454-63.
49. Shlomchik WD, Couzens MS, Tang CB et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 1999;285:412-5.